The Society for Vascular Surgery (SVS) and the American College of Cardiology (ACC) have completed a move to create a single vascular registry.
The new joint venture is designed to harness the strengths of both organizations in improving care and outcomes of patients with vascular disease.
Effective Jan. 1, the single registry is now operated by the SVS, creating a co-branded Vascular Quality Initiative (VQI) program that is seen as a unique and comprehensive resource for measuring and improving the care provided to a growing population of patients with vascular diseases.
The ACC’s Peripheral Vascular Intervention (PVI) Registry will not enroll new hospitals for 2021, but will now be managed by SVS, the two societies explained. The ACC data collection tool will remain open through April 15 to allow sites to complete data entry for the fourth quarter of 2020 and receive a final 2020 outcomes report. Hospitals will be able to access their historical PVI Registry data through Dec. 31, allowing hospitals time to determine how they would like to store or transfer these past records and reports.
ACC National Cardiovascular Data Registry (NCDR) participants who have not yet joined the SVS VQI may contact the SVS VQI account team by emailing firstname.lastname@example.org, or by calling 603-298-6717, to begin enrollment.
The new registry collaboration provides greater opportunities to evaluate new and emerging technologies, pharmacologic therapies, and medical and lifestyle management, the SVS and ACC say.
“The combined strengths of ACC and SVS provide a clear choice for clinicians, researchers, industry and the Food and Drug Administration [FDA] when looking for data on the management of vascular diseases,” said Fred Masoudi, MD, the ACC NCDR Oversight Committee chair and chief scientific advisor.
“This single registry combines the resources and expertise from both organizations. We have merged the best elements of both registries to create the premier vascular clinical registry,” said VQI medical director Jens Eldrup-Jorgensen, MD. “We look forward to working with the ACC and other medical society collaborators to enrich the VQI and improve the care of vascular patients.”
Originating as the CARE Registry in 2006 and expanding scope in 2014 to include lower-extremity vascular catheter-based interventions, the ACC’s Peripheral Vascular Intervention (PVI) Registry assesses the prevalence, demographics, management and outcomes of patients undergoing percutaneous treatment for peripheral vascular disease. To date, the PVI Registry includes patient data from more than 200 institutions.
VQI began in 2010 as an expansion of the Vascular Study Group of New England, which originated in 2003. More than 750 centers participate in VQI, which has 14 procedural-based registries encompassing the treatment of arterial and venous disease as well as a disease-based registry collecting data on the medical management of aneurysms, carotid stenosis and lower-extremity arterial occlusive disease.